Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0009324
Disease: Ulcerative Colitis
Ulcerative Colitis
0.320 Biomarker disease BEFREE Thus, F. nucleatum orchestrates a molecular network involving CARD3 and IL-17F to control the UC process. 31610014 2020
CUI: C0009324
Disease: Ulcerative Colitis
Ulcerative Colitis
0.320 AlteredExpression disease BEFREE The present study was aimed at describing expression of innate immunity genes (NOD2, RIP2, α-defensins HD5 and HD6) in inflamed colon and in ileum of children with ulcerative colitis. 20452301 2010
CUI: C0009324
Disease: Ulcerative Colitis
Ulcerative Colitis
0.320 Biomarker disease CTD_human The present study was aimed at describing expression of innate immunity genes (NOD2, RIP2, α-defensins HD5 and HD6) in inflamed colon and in ileum of children with ulcerative colitis. 20452301 2010
CUI: C0023343
Disease: Leprosy
Leprosy
0.100 GeneticVariation disease GWASDB Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. 22019778 2011
CUI: C0023343
Disease: Leprosy
Leprosy
0.100 GeneticVariation disease GWASDB Genomewide association study of leprosy. 20018961 2009
CUI: C0023343
Disease: Leprosy
Leprosy
0.100 GeneticVariation disease GWASCAT Genomewide association study of leprosy. 20018961 2009
CUI: C1290884
Disease: Inflammatory disorder
Inflammatory disorder
0.040 Biomarker group BEFREE Genetic loss or pharmaceutical inhibition of RIP2 has been shown to be beneficial in multiple inflammatory disease models with the effects largely attributed to reducing proinflammatory signaling downstream of peptidoglycan recognition. 31113864 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.040 Biomarker group BEFREE Monotherapy with CCKR blockade significantly decreased tumor size and metastases in SCID mice with orthotopic PDAC, and in C57BL/6 mice, it reduced fibrosis and induced the influx of TILs. 29043413 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.040 Biomarker group BEFREE Receptor‑interacting protein 2 (RIP2) has recently been reported to be involved in tumor infiltration and cancer metastasis. 29693188 2018
CUI: C1290884
Disease: Inflammatory disorder
Inflammatory disorder
0.040 GeneticVariation group BEFREE Further we show a second allele of RIPK2 linked to an inflammatory disease associated with arthritis also has enhanced activity stimulating the NF-κB pathway. 29659823 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.040 Biomarker group BEFREE A xenograft mouse model was used to assess tumor growth and chemosensitivity to docetaxel in vivo in MDA-MB-231 cells with and without RIP2 small hairpin RNA knockdown. 24642040 2014
CUI: C1290884
Disease: Inflammatory disorder
Inflammatory disorder
0.040 Biomarker group BEFREE In vivo inhibition of RIPK2 kinase alleviates inflammatory disease. 25213858 2014
CUI: C1290884
Disease: Inflammatory disorder
Inflammatory disorder
0.040 Biomarker group BEFREE This article reviews the role that the NOD2:RIP2 complex plays in inflammatory disease, with an emphasis on the inhibition of this signaling pathway as a novel pharmaceutical target in inflammatory disease. 23794710 2013
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.040 Biomarker group BEFREE Receptor-interacting serine/threonine protein kinase-2 (RIPK2) has been reported to be an important regulator of tumor proliferation, differentiation and wound repair. 22993319 2012
CUI: C0004623
Disease: Bacterial Infections
Bacterial Infections
0.030 Biomarker group BEFREE Furthermore, the expression of zebrafish histone H2A was decreased by RIP2 deficiency with and/or without bacterial infection. 31336107 2019
CUI: C0004623
Disease: Bacterial Infections
Bacterial Infections
0.030 AlteredExpression group BEFREE The results showed that NOD1 can identify LPS and activate the NF-κB signal pathway by recruiting RIPK2 and then promoting the expression of inflammatory cytokines to induce the resistance of organism against bacterial infection. 30013548 2018
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.030 Biomarker group BEFREE Receptor‑interacting protein 2 (RIP2) has recently been reported to be involved in tumor infiltration and cancer metastasis. 29693188 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.030 Biomarker phenotype BEFREE Indeed, we can demonstrate that RIPK2 activity correlated with advanced tumor, metastasis, and group stage as well as body mass index (BMI) to indicate that RIPK2 might be a useful prognostic marker for IBC and advanced stage breast cancer. 29874851 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.030 Biomarker phenotype BEFREE Receptor‑interacting protein 2 (RIP2) has recently been reported to be involved in tumor infiltration and cancer metastasis. 29693188 2018
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.030 Biomarker group BEFREE Receptor‑interacting protein 2 (RIP2) has recently been reported to be involved in tumor infiltration and cancer metastasis. 29693188 2018
CUI: C0004623
Disease: Bacterial Infections
Bacterial Infections
0.030 Biomarker group BEFREE Collectively, these findings demonstrate that NOD1 detects PG within early endosomes, thereby promoting RIP2-dependent autophagy and inflammatory signaling in response to bacterial infection. 24746552 2014
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.030 Biomarker group BEFREE A total of six breast cancer expression databases, including The Cancer Genome Atlas, were assessed for RIP2 expression among various clinical subtypes and its role as a prognostic biomarker. mRNA fluorescence in situ hybridization (FISH) for RIP2 was performed on 17 stage III breast cancers to determine if there was a correlation between RIP2 expression and lymph node involvement. 24642040 2014
CUI: C0010346
Disease: Crohn Disease
Crohn Disease
0.030 Biomarker disease BEFREE Using these markers and the FDA-approved RIPK2 inhibitor Gefitinib, we show that pharmacologic RIPK2 inhibition drastically improves disease in a spontaneous model of Crohn Disease-like ileitis. 25213858 2014
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.030 Biomarker phenotype BEFREE These results highlight RIP2 as a pro-metastasis kinase in patients with advanced breast cancer. 24642040 2014
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.030 Biomarker group BEFREE A total of six breast cancer expression databases, including The Cancer Genome Atlas, were assessed for RIP2 expression among various clinical subtypes and its role as a prognostic biomarker. mRNA fluorescence in situ hybridization (FISH) for RIP2 was performed on 17 stage III breast cancers to determine if there was a correlation between RIP2 expression and lymph node involvement. 24642040 2014